Supernus Pharmaceuticals | SUPN - Operating Profit



Supernus Pharmaceuticals reported $12.14M in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Abbott USD 2.07B 415M Jun/2025
ANI Pharmaceuticals USD 15.17M 11.02M Jun/2025
Aurora Cannabis CAD -20220000 56.44M Jun/2025
Bristol-Myers Squibb USD 3.77B 366M Jun/2025
Canopy Growth CAD -22080000 1.74M Jun/2025
Corcept Therapeutics USD 26.67M 23.26M Jun/2025
Eisai JPY 20.74B 21.77B Jun/2025
Eli Lilly USD 7.02B 1.61B Jun/2025
Novo Nordisk 34.08B 4.71B Jun/2025
Pacira USD 10.23M 8.24M Jun/2025
Perrigo USD 55.6M 23.8M Jun/2025
Pfizer USD 2.6B 1.06B Jun/2025
Supernus Pharmaceuticals USD 12.14M 14.74M Jun/2025
United Therapeutics USD 276.9M 105.9M Jun/2025
Xeris Pharmaceuticals USD 4.48M 2.8M Jun/2025